BackgroundObstructive urolithiasis commonly affects male goats. Perineal urethrostomy (PU) can be a permanent treatment option but is generally considered undesirable because of the risk of stricture of the urethral stoma. Limited information exists regarding long‐term outcome and complications in goats undergoing PU for treatment of obstructive urolithiasis.ObjectivesTo determine short‐term and long‐term outcome and complications in goats undergoing PU for treatment of obstructive urolithiasis.AnimalsTwenty‐five client‐owned goats.MethodsMulti‐institutional retrospective case series.ResultsOf the 25 goats, 13 (52%) were alive at the time of follow‐up. Mean time from surgery to follow‐up was 34 months (range, 4‐65). Nine goats (36%) died between discharge and follow‐up with a mean survival time of 46 days (range, 5‐120). Cause of death in 7 of 9 (78%) goats was related to urolithiasis. Goats treated by use of a modified proximal perineal urethrostomy (MPPU) were significantly more likely to survive at least 150 days postoperatively (P < .01). The most common postoperative complications were hemorrhage (10/25 [40%]) and surgical site infection (3/25 [12%]). Hemorrhage was significantly associated with MPPU (P < .0001). Stricture of the surgical stoma occurred in 7 of 22 (32%) discharged goats. Mean time to stricture was 65 days (range, 10‐240).Conclusions and Clinical ImportancePerineal urethrostomy can provide effective long‐term resolution of obstructive urolithiasis in goats. Re‐obstruction or stricture seems most likely within the 1st 2 months after surgery. MPPU may provide better long‐term results but should be approached cautiously because it can be associated with life‐threatening hemorrhage.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.